Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study Article

publication date

  • March 28, 2023

webpage

published in

keywords

  • IL-17
  • Psoriasis
  • Psoriasis transcriptome
  • Secukinumab

start page

  • 12

end page

  • 21

volume

  • 109

issue

  • 1